Notice of Correction (DOI:10.1016/j.jtcvs.2006.11.043);Life-supporting function of genetically modified swine lungs in baboons

Journal of Thoracic and Cardiovascular Surgery

Volumn 133, Issue 5, 2007, Pages 1354-1363

  Nguyen, Bao Ngoc H ^a   Azimzadeh, Agnes M ^a   Zhang, Tianshu ^a   Wu, Guosheng ^a   Shuurman, Henk Jan ^b   Sachs, David H ^c   Ayares, David ^d   Allan, James S ^c   Pierson III, Richard N ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b Immerge Biotherapeutics Inc   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d REVIVICOR INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA THROMBOGLOBULIN; GALACTOSYLTRANSFERASE; MEMBRANE COFACTOR PROTEIN; THROMBIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BABOON; CONTROLLED STUDY; DNA MODIFICATION; IN VIVO STUDY; LONG TERM CARE; LUNG FUNCTION; LUNG TRANSPLANTATION; LUNG VASCULAR RESISTANCE; MONOCYTE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SWINE; THROMBOCYTE; TRANSGENIC MOUSE; XENOGRAFT;

EID: 34247328961     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2007.11.005     Document Type: Erratum

References (30)

1. Leventhal J.R., John R., Fryer J.P., Dalmasso A., Matas A.J., Bolman R.M., et al. Removal of baboon and human antiporcine IgG and IgM natural antibodies by immunoadsorption. Transplantation 59 (1995) 294-300
2. Azimzadeh A., Meyer C., Watier H., Jaeck D., Cinqualbre J., Wolf P., et al. Removal of primate xenoreactive natural antibodies by extracorporeal perfusion of pig kidneys and livers. Transplant Immunol 6 (1998) 13-22
3. Katopodis A.G., Warner R.G., Duthaler R.O., Davies H.F., Manez R., White D., et al. Removal of anti-Galalpha1,3Gal xenoantibodies with an injectable polymer. J Clin Invest 110 (2002) 1869-1877
4. Azimzadeh A., Zorn G.L., Blair K.S., Cozzi E., White D.J., Pierson III R.N., et al. Hyperacute lung rejection in the pig-to-human model. 2. Synergy between soluble and membrane complement inhibition. Xenotransplantation 10 (2003) 120-131
5. Schroeder C., Pfeiffer S., Wu G., Zorn III G.L., Ding L., Allen C., et al. Effect of complement fragment 1 esterase inhibition on survival of human decay-accelerating factor pig lungs perfused with human blood. J Heart Lung Transplant 22 (2003) 1365-1375
6. Cozzi E., and White D.J.G. The generation of transgenic pigs as potential organ donors for humans. Nat Med 1 (1995) 964-966
7. Zaidi A., Schmoeckel M., Bhatti F., Wallwork J., White D., Friend P., et al. Life-supporting pig-to-primate renal xenotransplantation using genetically modified donors. Transplantation 65 (1998) 1584-1590
8. Daggett C.W., Yeatman M., Lodge A.J., Frank M.M., Platt J.L., Davis R.D., et al. Total respiratory support from swine lungs in primate recipients. J Thorac Cardiovasc Surg 115 (1998) 19-27
9. Yeatman M., Daggett C.W., Lau C.L., Logan J.S., Platt J.L., Davis R.D., et al. Human complement regulatory proteins protect swine lungs from xenogeneic injury. Ann Thorac Surg 67 (1999) 769-775
10. Yeatman M., Daggett C.W., Parker W., Logan J.S., Platt J.L., Davis R.D., et al. Complement-mediated pulmonary xenograft injury: studies in swine-to-primate orthotopic single lung transplant models. Transplantation 65 (1998) 1084-1093
11. Kulick D.M., Salerno C.T., Dalmasso A.P., Paz M.G., Fodor W.L., and Bolman III R.M. Transgenic swine lungs expressing human CD59 are protected from injury in a pig-to-human model of xenotransplantation. J Thorac Cardiovasc Surg 119 (2000) 690-699
12. Lau C.L., Daggett W.C., Yeatman M.F., Parker W., Platt J.L., Davis R.D., et al. The role of antibodies in dysfunction of pig-to-baboon pulmonary transplants. J Thorac Cardiovasc Surg 120 (2000) 29-38
13. Blum M.G., Chang A.C., Collins B.H., Knaus S.A., Christman B.W., and Pierson III R.N. The effect of nitric oxide and thromboxane blockade on pulmonary vascular resistance in a pig to primate lung transplant model (1997) 290 The Fourth International Congress for Xenotransplantation; Nantes, France: abstract
14. Azimzadeh A., Schroeder C., and Pierson III R.N. Lung xenotransplantation. In: Banner N. (Ed). Lung transplantation. 1st ed. (2003), Cambridge University Press, Cambridge [UK] 374-385
15. Kolber-Simonds D., Lai L., Watt S.R., Forsberg E.J., Prather R.S., Hawley R.J., et al. Production of alpha-1,3-galactosyltransferase null pigs by means of nuclear transfer with fibroblasts bearing loss of heterozygosity mutations. Proc Natl Acad Sci U S A 101 (2004) 7335-7340
16. Ayares D., Colman A., Dai Y., Shiels P., and Moore M. Cloning pigs deficient in alpha 1,3 galactosyltransferase. Graft 4 (2001) 80-82
17. Tseng Y.L., Kuwaki K., Dor F.J., Schuurman H.J., Sachs D.H., Cooper D.K., et al. Alpha 1,3-galactosyltransferase gene-knockout pig heart transplantation in baboons with survival approaching 6 months. Transplantation 80 (2005) 1493-1500
18. Yamada K., Yazawa K., Shimizu A., Awwad M., Sykes M., Sachs D.H., et al. Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha 1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue. Nat Med 11 (2005) 32-34
19. Schroeder C., Allan J.S., Nguyen B.N., Shuurman H.-J., Sachs D.H., and Pierson III R.N. Hyperacute rejection is attenuated in GalT-KO swine lungs perfused ex vivo with human blood. Transplant Proc 37 (2005) 512-513
20. Gonzalez-Stawinski G.V., Daggett C.W., Lau C.L., Gaca J.G., Parker W., Davis Jr. R.D., et al. Non-anti-Gal alpha1-3Gal antibody mechanisms are sufficient to cause hyperacute lung dysfunction in pulmonary xenotransplantation. J Am Coll Surg 194 (2002) 765-773
21. Kaplon R.J., Platt J.L., Kwiatkowski P.A., Shah A.S., Masroor S., and Michler R.E. Absence of hyperacute rejection in pig-to-primate orthotopic pulmonary xenografts. Transplantation 59 (1995) 410-416
22. Pfeiffer S., Zorn III G.L., Zhang J.P., Robson S.C., Azimzadeh A.M., and Pierson III R.N. Hyperacute lung rejection in the pig-to-human model. III. Platelet receptor inhibitors synergistically modulate complement activation and lung injury. Transplantation 75 (2003) 953-959
23. Nguyen B.N., Zwets E., Schroeder C., Pierson III R.N., and Azimzadeh A.M. Beyond antibody-mediated rejection: hyperacute lung rejection as a paradigm for dysregulated inflammation. Curr Drug Targets Cardiovasc Haematol Disord 5 (2005) 255-269
24. Collins B.J., Blum M.G., Parker R.E., Zorn G.L., Chrisman B.W., and Pierson R.N. Thromboxane mediates pulmonary hypertension and contributes to lung inflammation during hyperacute lung rejection. J Appl Physiol 90 (2000) 2257-2268
25. Siegel J.B., Grey S.T., Lesnikoshi B.-A., Kopp C.W., Soares M., and Robson S.C. Xenogeneic endothelial cells activate human prothrombin. Transplantation 64 (1997) 888-896
26. Robson S.C., Cooper D.K., and d'Apice A.D. Disordered regulation of coagulation and platelet activation in xenotransplantation. Xenotransplantation 7 (2000) 166-176
27. Jurd K.M., Gibbs R.V., and Hunt G. Activation of human prothrombin by porcine aortic endothelial cells-a potential barrier to pig to human xenotransplantation. Blood Coag Fibrinol 7 (1996) 336-343
28. Chen D., Riesbeck K., McVey J.H., Tuddenham E.G., Lehler R.I., Dorling A., et al. Human thrombin and FXa mediate porcine endothelial cell activation, modulation by expression of TFPI-CD4 and hirudin-CD4 fusion proteins. Xenotransplantation 8 (2001) 258-265
29. Zorn G.L., Pfeiffer S., Azimzadeh A.M., and Pierson III R.N. Thrombin inhibition protects the pulmonary xenograft from hyperacute rejection. Surg Forum LI (2000) 338-340
30. Peterson M.D., Jin R., Hyduk S., Duchesneau P., Cybulsky M.I., and Waddell T.K. Monocyte adhesion to xenogeneic endothelium during laminar flow is dependent on alpha-gal-mediated monocyte activation. J Immunol 174 (2005) 8072-8081